Does compounded semaglutide worsen gastroparesis?

Question

Hello doctor.

I started taking compounded Semaglutide for weight loss three weeks ago, following a prescription from a clinic. I was instructed to take a 0.25 mg dose once a week, but after my second dose, I began experiencing extreme nausea, acid reflux, and severe bloating. It feels much worse than what I have read about the standard version of Semaglutide. I asked my pharmacist about the formulation, and they mentioned that it includes additional stabilizers to prolong the effect. Could these additives be responsible for my symptoms? Also, is there any way to verify if the compounded version has the correct active ingredient? Should I consider stopping it and switching to a brand-name version, even if it is more expensive? Additionally, I have a history of mild gastroparesis. Could Semaglutide worsen this condition over time? I do not want to continue if it is going to lead to long-term digestive problems.

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I understand your concern.

Certain factors could be contributing to your symptoms. The additives present in the compounded formulation might be responsible for your adverse reactions, as they can introduce stabilizers not found in the brand-name version. Additionally, if you have a pre-existing condition such as gastroparesis, it could be exacerbating your gastrointestinal side effects. Individual tolerance also plays a role, as some individuals may be more sensitive to either the active ingredient itself or the specific composition of the compounded formulation. To verify the compounded version, it is advisable to contact the compounding pharmacy and inquire about the formulation, including the active ingredient, additives, and concentration. Checking for third-party verification, such as accreditation from the Pharmacy Compounding Accreditation Board (PCAB), can also provide reassurance regarding quality and safety.

Switching to a brand-name version like Wegovy may be worth considering, as it has a standardized formulation that could reduce the risk of adverse reactions. Additionally, Semaglutide has undergone extensive clinical trials, ensuring more comprehensive data on safety and efficacy. However, cost and insurance coverage should be taken into account, and discussing options with your healthcare provider can help determine the best course of action. If you have concerns about gastroparesis, monitoring your gastrointestinal symptoms closely and consulting your healthcare provider about your medical history is essential for appropriate management. Lastly, it is important to note that compounded Semaglutide has not been approved by the FDA (Food and Drug Administration).

I hope this helps you.

Thank you.